Dialysis News

• When Should Those With End-Stage Kidney Disease Forego Dialysis? Australia and the UK have long had programs whereby some elderly patients with end-stage kidney disease, or those with many comorbidities, opt to forego dialysis, but the US has lagged behind.
  Medscape Medical News, May 23, 2022
• Can Individualized Care for Kidney Disease in HIV Improve Outcomes? A need for dose adjustments and the possibility of drug-drug interactions have been identified in a study of advanced kidney disease in persons living with HIV.
  Medscape Medical News, May 09, 2022
• HBCU Medical Schools to Tackle Organ Transplant Disparities The collaboration follows a National Academies of Sciences, Engineering and Medicine report that found significant disparities in the nation's organ transplant system.
  Associated Press, May 05, 2022
• First-Ever Best Practices for Percutaneous Axillary Access A new position statement from the Society for Cardiovascular Angiography and Interventions suggests best practices for this increasingly widespread alternative access route.
  Medscape Medical News, April 28, 2022
• Potassium Abnormalities Boost Hospital Visits for Kidney Disease Patients with advanced chronic kidney disease who have hyper- or hypokalemia are at higher risk for ER visits and hospitalization, especially those with high potassium levels.
  Medscape Medical News, April 25, 2022
• Doc's Condiment Crusade Helps Patients Kick Salt Habit New Orleans nephrologist Dr Adrian Baudy IV brews a no-salt hot sauce that packs a punch but is kind on the kidneys.
  Medscape Medical News, April 22, 2022
• Shanghai Patients Crowdsource Medical Help During COVID Lockdown Shanghai residents have turned online for grassroots help on medical treatment as the city's tough COVID-19 curbs limit access to healthcare and fuel frustration and anxiety.
  Reuters Health Information, April 12, 2022
• Daprodustat an Oral Alternative to ESAs in Kidney Patients Starting Dialysis Oral daprodustat works as well as injected darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease starting dialysis, according to results of the ASCEND-ID trial.
  Reuters Health Information, April 04, 2022
• FDA Turns Down Vadadustat for CKD Anemia Vadadustat is the second agent from the HIF-PHI class to fail to receive FDA marketing approval because of safety. A third agent from the class, daprodustat, has not yet undergone FDA review.
  Medscape Medical News, March 31, 2022
• End-Stage Kidney Disease Doubles: Treat Patients Earlier to Prevent It Patients with end-stage kidney disease doubled over the last 20 years, leading to calls for better management of conditions that cause it. An intervention among Native Americans has had some impact.
  Medscape Medical News, March 25, 2022
• Opting Out of Dialysis Not Instant Death Sentence for Kidney Disease Patients with advanced kidney disease who forgo dialysis still have a reasonable quality of life, with survival rates of several years for many.
  Medscape Medical News, March 15, 2022
• ISN 2022 FDA Rejects Bardoxolone as First Alport Syndrome Agent Alport syndrome, a rare genetic disease that causes early kidney failure, continues to have no approved treatment, but advocates foresee progress in diagnosis and awareness from the failed approval attempt.
  Medscape Medical News, March 15, 2022
• Kidney Policy Increases Patient Referrals, Evaluations Implementation of the kidney allocation system led to increased patient referrals by dialysis centers and more evaluations by transplant centers. Fewer evaluated patients were waitlisted than before.
  Medscape Medical News, March 14, 2022
• Use of High-Dose Iron in Dialysis in US Tracks PIVOTAL Trial The 2019 landmark PIVOTAL trial that established the safety and efficacy of higher-dose iron in patients on hemodialysis had little discernable impact on US practice, which already used higher doses.
  Medscape Medical News, February 22, 2022
• Fewer Diabetes Complications With NOACs in Patients With AFib Patients with both diabetes and atrial fibrillation may derive greater benefits from non-vitamin K oral anticoagulants than from warfarin, a new study has found.
  Medscape Medical News, February 15, 2022
• Patients With CKD May Feel Hindered in Research Participation Patients and caregivers may avoid clinical research participation due to stigmatization and unfamiliarity with the research setting, finds a new study, offering insight for health professionals.
  Medscape Medical News, February 07, 2022
• Death Rates Stay High Among Patients With Acute Kidney Injury More than one in four patients who develop acute kidney injury die within 1 year of being hospitalized, with little improvement in survival over the past decade.
  Medscape Medical News, February 07, 2022
• No COVID Vax, No Transplant: Unfair or Good Medicine? COVID vaccinations — and some people's resistance to them — have turned what used to be routine preparation controversial.
  WebMD Health News, February 04, 2022
• Antimineralocorticoids May Protect Against Kidney Failure in CKD For patients with chronic kidney disease, treatment with a mineralocorticoid-receptor antagonist appears to protect against kidney failure requiring renal replacement therapy, according to a retrospective cohort study.
  Reuters Health Information, February 03, 2022
• Cancer, Infection Risk Higher in Tx Patients Than Rejection Cancer, infection, and heart disease emerge as key risk factors for death with graft function in kidney transplant patients while organ rejection accounts for far fewer graft losses.
  Medscape Medical News, January 27, 2022